The low EOMES/TBX21 molecular phenotype in multiple sclerosis reflects CD56+ cell dysregulation and is affected by immunomodulatory therapies.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Anita Goldinger Allan G. Kermode Steve Vucic Fiona C McKay |
| Publication date | January 4, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |